Petra Štefanič Anderluh
As the General Director of Novartis d. o. o. in Slovenia, Petra Štefanič Anderluh leads the only pharmaceutical company in the country that focuses on the development and production of innovative, breakthrough medicines. She emphasizes the importance of collaboration among stakeholders to create an environment conducive to investment and innovation in healthcare, ensuring access to essential medicines for patients both locally and globally.
Not in the pool (under ¢1).
Recent news mentions
Petra Štefanič Anderluh is the general director of Novartis in Slovenia and emphasized the importance of excellence in pharmaceutical production.
V Novartisovi tovarni v Ljubljani delo za 300 strokovnjakov
Slovenia· 2026-07-02
Petra Štefanič Anderluh is the general director of Novartis and emphasizes Slovenia's importance in advanced pharmaceutical production.
Koliko nas v resnici stane slabo zdravje?Slovenia· 2026-06-22
Petra Štefanič Anderluh is the general director of Novartis in Slovenia and explained the company's significant investment in new technologies.
Odprtje tovarne v Mengšu velik mejnik tudi za NovartisSlovenia· 2026-03-04
Petra Štefanič Anderluh is the general director of Novartis d. o. o.
Prihodnost slovenskega zdravstvenega sistema na razpotjuSlovenia· 2025-07-30